Tuberculosis : The Rate Of Deaths And Cases Of Tuberculosis

With the close proximity infection range TB is known for completes the remainder of the epidemiologic triangle. Overcrowded environments are the coal to the fire of this transmittable disease with outbreaks capable of occurring, infection hundreds. Common symptoms of this active form of tuberculosis include: weight loss, coughing, fatigue, fever, night sweats, chills, and loss of appetite (MayoClinic, 2014). The Mayo Clinic also states that it is believed that 2 billion (one third) of the world population is living with Latent TB (2014). This emphasizes the need for public health and community involvement in order to completely abolish this disease from our planet.

Tuberculosis has been a persistent threat to the human race as far back as Hippocrates (c.460-c.370 BC). Globally, tuberculosis has infected millions during waves, often killing scores of people at a time, and then receding giving it an almost supernatural quality (Daniel, 2006). In recent history tuberculosis has been recorded in all corners of the world, and currently infects one third of the global population. In 2012, TB was responsible for killing 1.3 million people, making it the second largest fatal disease next to AIDS. The purpose of this paper is to describe tuberculosis, explain contributing factors, describe the disease in relation to the epidemiologic triangle, and finally

TB is still proven to be a top killer around the world, and with more cases of drug resistant TB being reported daily, the cost of treating and preventing this disease will continue to be on the rise.

Tuberculosis is a deadly disease that is now affecting our world and the people living in it in a horrible way. Due to many factors such as poverty, HIV/AIDS, and lack of health care, many third world and developing countries have been left very vulnerable to tuberculosis. It is affecting a large part of these countries and is leading them deeper into poverty and sickness. The effort to help these countries against tuberculosis has only been slightly effective against this widespread and destructive disease.

Tuberculosis has been part of human history for a long time but how long is a long time? Recent research using genetic data has allowed us to know that the tuberculosis progenitor has been on this planet for about 3 million years affecting even our earlier ancestors (Gutierrez et al, 2005). Additionally this research showed that the bacilli from tuberculosis are capable of mixing sections of their genome with other strains and giving the pathogen a composite assembly, which resulted from ancient horizontal exchanges before its clonal expansion. This quality provided tuberculosis a big advantage that even now a days allows the organism to evade, adapt and create resistance to treatments that were once successful. In order to fix current and

Tuberculosis (TB) is an infectious killer worldwide. However, over 95% of TB deaths occur in developing countries (WHO). TB is found to be a curable disease when appropriate medications and treatment are taken. Using the biomedical system is not sufficient to eradicate TB because medical interventions will fail if social determinates aren’t taken into considerations. The biomedical system is a key component in diminishing TB because it allows for diagnosis and control. Social determinants of health play a huge role in shaping one’s health. Three main social determinants that acts as a barrier in curing and preventing TB are income, food insecurity and access to health care.

Once believed to be easily treated and prevented, Tuberculosis (TB) has recently been making a steady comeback. Previous to modern medicine, TB claimed millions of victims, spreading from person to person like wildfire. Around the 17th-18th centuries, the “White Plague” took the lives of 1 in 5 adults (20%) in Europe and North America (Iseman, 1994). However, as technological advances progressed, this seemingly ferocious viral disease became a primal, insignificant thing of the past. But, in the nature of all bacteria, TB has, in the recent years, mutated to become progressively drug resistant. Why is Tuberculosis coming back with a vengeance? Well, the answer’s quite simple. TB has done an amazing job of standing in the corner and

Tuberculosis, the white plague as used to be called once upon a time is still one of the deadliest bacterial killers affecting almost all parts, all corners of the globe. Though successful anti-tubercular antibiotic regimens and effective vaccine are available for decades and being used in the battle against Koch’s bacillus, Mycobacterium tuberculosis, the causative agent of this chronic multi organ granulomatous disease, our strand in the battle continuously seems to be in the losing side. Moreover the increasing prevalence of HIV-AIDS and diabetes mellitus is being proved to be providing predisposition to tuberculosis. As witnessed by the WHO, which has estimated that, in the year 2012, 8.6 million people have developed tuberculosis and 1.3 million have died of the disease including 320000 deaths of HIV-TB co-infected people (Global tuberculosis report 2013. World Health Organization; 2013). Long term antibiotic therapy and that too associated with several side effects and discomforts have diminished patient compliance with the anti-tubercular chemotherapy. This fact in turn has raised the new deadlier MDR-TB and XDR-TB strains. The whole scenario is a matter of panic and questioning the effectiveness of anti-tubercular antibiotics, immunologic efficacy of century old BCG vaccine and all other medical advents.

TB is the most common cause of infectious disease–related mortality worldwide. in 2014, TB killed 1.5 million people (1.1 million HIV-negative and 0.4 million HIV-positive). The disease included 890 000 men, 480 000 women and 140 000 children. TB now ranks alongside HIV as a leading cause of death worldwide. HIV’s death in 2014 was estimated at 1.2 Million, which included the 0.4 million TB deaths among HIV positive people. Worldwide, 9.6 million people are estimated to have fallen ill with TB in 2014: 5.4 million men, 3.2 million women and 1.0 million children. Globally, 12% of the 9.6 million new TB cases in 2014 were

Tuberculosis is the one of the world’s second deadliest disease; having killed around 1.5 million people in the year 2013, second only to HIV/AIDS. Around 3 million cases, which equates to one-third of the global total, go undiagnosed and hundreds more cases are considered to be a drug-resistant form of the disease. A search done on the New York Times’ website turns up 10 articles with the word “tuberculosis” in the headline published over the past 12 months while “HIV and AIDS” turns up 91 articles (Gould, 2015). The sad reality is that tuberculosis is not given enough attention compared to other well-known diseases such as HIV/AIDS. Tuberculosis is considered a disease of the past and not an immediate threat to developed nations; not to mention that it is just not profitable route for the health care industry to pursue. Although, when processing all this information, we tend to forget that HIV/AIDS and tuberculosis go hand-in-hand, as tuberculosis is an opportunistic disease for AIDS patients in sub-Saharan Africa and workers/patients in medical and correctional facilities.

Tuberculosis (TB) continue to be a major public health problem world wide (Lönnroth, Migliori, Abubakar, D’Ambrosio, de Vries, Diel,…Raviglione, 2015). Approximately one-third of the worlds population is infected with the bacteria Mycobacterium tuberculosis and are at risk for developing TB. The WHO’s Global Tuberculosis Report 2017 reported an astounding 10.4 million cases of confirmed TB and an estimated 1.8 million TB related death worldwide in 2016. Unfortunately, 95 percent of the global TB pandemic are in low- and middle-income countries where there is a lack of resources to combat or appropriately address such issue.

Over 15 years ago, the World Health Organization set a goal to halt and reverse the incidence of tuberculosis. Millennium Development Goal #6 is combat diseases like Malaria, AIDS, and tuberculosis. The international community has worked together using preventative and treatment measures in efforts to reach this goal and eradicating diseases. While tuberculosis is a quickly spreading and multifaceted disease, the goal has had to adapt to the changing nature of the disease. Factors such as education, economics, and technology play important roles in eradicating tuberculosis across the world (Skolnik, 2012). While there is an extremely low prevalence of tuberculosis in developed countries, tuberculosis runs rampant and is harder to reach and combat in poorer and developing countries, particularly sub-saharan Africa and south-east Asia. Tuberculosis is one of the infectious diseases health experts and advocates are working to eliminate. Additionally, they hope to improve health access and reduce health disparities to prevent the spread of future infectious disease.

The Centers of Disease Control and Prevention (2016) indicates that tuberculosis is one of the contagious diseases which are caused by mycobacterium tuberculosis bacteria. The disease can affect the lungs; however, it can potentially affect all over the body and kill the person. According to World Health Organization (2016), 9.6 million people became ill from TB and 1.5 million people died from disease in 2014. People death ratio from tuberculosis is three times higher than HIV infection (World Health Organization, 2016). Mostly people are affected with tuberculosis disease in Asia and Africa country, whereas the incidence rate

Although Africa and other developing nations lead in the number of those infected with tuberculosis, the infected population in the world is currently estimated to be at around one third of the

India, the second most populous country with over 1.31 billion people, has the highest burden of tuberculosis (TB) in the world, accounting for 20% of the global incidence of TB, and an even higher share of global incidence of multi–drug resistant (MDR) TB. With an estimated 2 million new cases of TB and 5, 00,000 TB-related deaths in India annually, those who got diagnosed with different forms of DR-TB were 35,385 cases but only 20,753 people started on multidrug-resistant TB (MDR-TB) treatment in 2013. The National Tuberculosis Program was launched in 1962, but suffered heavily continuing TB led mortality. Acknowledging this reality, a Revised National Tuberculosis Control Programme (RNTCP) was launched by the Government of India in 1997, however even today it does not comply with World Health Organization (WHO) recommendations.